Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
ID: 355543Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355543
Timeline
    Description

    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI Research Specialist (Clinician Scientist) Award (R50), which will not allow clinical trials. This grant aims to support clinician scientists involved in NCI-funded clinical trials research by fostering stable research career opportunities and encouraging leadership in the development and implementation of clinical trials. The award is particularly significant as it seeks to enhance participation in NCI clinical trials networks, ensuring a diverse representation of institutions in the application process. The Notice of Funding Opportunity (NOFO) is expected to be published in late summer 2024, with a single application due date of November 5, 2024, and an estimated award date of May 30, 2025. Interested applicants should prepare their submissions accordingly, as applications are limited to four per institution.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Research Specialist (Clinician Scientist) Award (R50), a federal grant aimed at supporting clinician scientists involved in NCI-funded clinical trials. This award is designed to provide salary support and autonomy for exceptional clinician scientists who will not serve as principal investigators but will lead in the development and implementation of national clinical trials and participate in scientific committees. The R50 Award is crucial for ensuring career stability in cancer research, allowing candidates to apply for new, renewal, or resubmission grants over a funding period of up to five years. Applications open on October 4, 2024, and interested parties can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NCI Research Specialist (Core-based Scientist) Award (R50), a federal grant aimed at supporting laboratory-based scientists involved in cancer research. This funding opportunity is designed to provide salary support and promote stable career paths for exceptional researchers who contribute significantly to NCI-funded projects but do not serve as independent investigators. The initiative emphasizes the importance of collaborative scientific support in advancing cancer research and aims to foster a sustainable research workforce, particularly among institutions serving underrepresented groups. Applications are open from October 2, 2023, with awards expected as early as November 2023, and interested parties can find more information and submit inquiries via grantsinfo@nih.gov. The project duration can extend up to five years, with funding covering the Research Specialist's salary and limited travel costs.
    NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the Research Specialist Award (R50), aimed at supporting laboratory-based scientists engaged in cancer research. This grant is designed for exceptional individuals who wish to continue their research within existing NCI-funded programs without transitioning to independent investigator roles, emphasizing the importance of non-tenure track scientists in sustaining the biomedical research enterprise. Eligible applicants include various higher education institutions and organizations, with funding covering salary support and travel costs for a maximum project duration of five years. The application deadline is November 1, 2024, with an anticipated project start date in March 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Pathway to Independence Award (K99/R00 � Independent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the NCI Pathway to Independence Award (K99/R00), which includes an optional independent clinical trial component. This program aims to support talented postdoctoral researchers with up to six years of postdoctoral research training experience, facilitating their transition to independent tenure-track faculty positions while providing essential NCI research support to help launch their careers in cancer research. The estimated synopsis post date is November 1, 2024, with applications expected to close by February 14, 2025, and awards anticipated to be made by January 2, 2026. Interested applicants are encouraged to prepare their proposals in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network (NCTN) - Network Group Operations Centers, which will require a U10 clinical trial. This initiative aims to provide scientific leadership for the development and implementation of multi-disciplinary, multi-institutional clinical trials targeting various cancer types and populations, focusing on late-phase treatment trials and advanced imaging studies. The funding, estimated at $99.3 million, is intended to support the conduct of essential clinical research for adults, adolescents, and children with cancer, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, applicants should prepare their submissions in advance of the anticipated award date of March 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.
    Notice of Intent to Publish a Funding Opportunity Announcement for Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for a single-source grant aimed at establishing the NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network. This initiative seeks to partner with private institutions of higher education to conduct large-scale, multi-site clinical trials, focusing on late-phase treatment trials and advanced imaging across various cancer types, while ensuring regulatory oversight in Canada. The funding, estimated at $3.8 million, is intended to support the NCTN's efforts to enhance clinical research for diverse patient populations, with the application due in late February 2025 and the award anticipated by March 1, 2026. Interested applicants should prepare their proposals in advance of the expected NOFO publication in Fall 2024.
    Notice of Intent to Publish a Funding Opportunity Announcement for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award for Clinical Oncology (K12), aimed at supporting institutional research career development programs for clinical scientists in cancer research. This initiative emphasizes training for clinical scientists who aspire to lead independent clinical trials or contribute to existing trials, thereby enhancing the field of clinical cancer research. The NOFO is anticipated to be released in November 2024, with the first application deadline set for February 2025, and the estimated award date is January 5, 2026. Interested applicants are encouraged to begin developing collaborations and applications in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network, specifically targeting Network Lead Academic Participating Sites through a cooperative agreement. The primary objective is to provide scientific leadership in developing and conducting multi-center clinical trials for various cancer treatments, contributing to substantial patient accrual across the NCTN. This initiative is crucial for advancing clinical research and improving treatment options for diverse patient populations affected by cancer. The estimated total program funding is $35,100,000, with an award ceiling of $1,700,000 and approximately 35 awards expected. Interested applicants should prepare for the anticipated application due date in late February 2025, following the NOFO publication in Fall 2024.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required). This initiative aims to provide statistical expertise for the design, conduct, and data management of multi-center clinical trials, particularly focusing on late-phase treatment trials across various cancer types and patient demographics. The funding, estimated at $47 million, will support approximately five awards, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, interested applicants should prepare their proposals in advance of the anticipated timeline.